KAS
DXCM icon

Kestra Advisory Services’s DexCom DXCM Stock Holding History

Kestra Advisory Services’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Buy
5,477
+1,275
+30% +$84.9K ﹤0.01% 2581
2026
Q1 		$264K Sell
4,202
-4,534
-52% -$316K ﹤0.01% 2740
2025
Q4 		$580K Buy
8,736
+1,430
+20% +$92.5K ﹤0.01% 2037
2025
Q3 		$492K Sell
7,306
-2,033
-22% -$161K ﹤0.01% 2083
2025
Q2 		$815K Sell
9,339
-492
-5% -$38.6K ﹤0.01% 1622
2025
Q1 		$671K Sell
9,831
-9,885
-50% -$807K ﹤0.01% 1633
2024
Q4 		$1.53M Buy
19,716
+1,304
+7% +$96.5K 0.01% 1146
2024
Q3 		$1.23M Buy
18,412
+4,126
+29% +$339K 0.01% 1210
2024
Q2 		$1.62M Sell
14,286
-128
-0.9% -$16.2K 0.01% 1068
2024
Q1 		$2M Buy
14,414
+172
+1% +$21.6K 0.01% 880
2023
Q4 		$1.77M Buy
14,242
+407
+3% +$41.6K 0.01% 849
2023
Q3 		$1.29M Sell
13,835
-1,785
-11% -$201K 0.01% 875
2023
Q2 		$2.01M Buy
15,620
+1,866
+14% +$226K 0.02% 670
2023
Q1 		$1.6M Sell
13,754
-14,213
-51% -$1.59M 0.02% 733
2022
Q4 		$3.17M Buy
27,967
+4,187
+18% +$460K 0.03% 573
2022
Q3 		$1.92M Sell
23,780
-7,053
-23% -$597K 0.02% 680
2022
Q2 		$2.3M Buy
30,833
+15,177
+97% +$1.39M 0.02% 623
2022
Q1 		$2M Buy
15,656
+6,360
+68% +$696K 0.02% 675
2021
Q4 		$1.25M Sell
9,296
-704
-7% -$101K 0.01% 884
2021
Q3 		$1.37M Buy
10,000
+1,492
+18% +$188K 0.01% 861
2021
Q2 		$908K Buy
8,508
+1,284
+18% +$123K 0.01% 996
2021
Q1 		$649K Buy
7,224
+568
+9% +$53.3K 0.01% 1070
2020
Q4 		$604K Buy
6,656
+6,436
+2,925% +$575K 0.01% 1110
2020
Q3 		$1.46M Buy
+220
New +$23K 0.03% 508

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Kestra Advisory Services's DXCM Position: Q2 2026 in Review

Kestra Advisory Services increased its DexCom (DXCM) stake by 30% in Q2 2026, buying an estimated $84.9K and bringing the position to 5,477 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2581.

Kestra Advisory Services first reported a position in DXCM in Q3 2020 and has held it in 24 quarters since. The position peaked at $3.17M in Q4 2022. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Kestra Advisory Services held 5,477 shares of DexCom worth $369K as of Q2 2026.
  • Kestra Advisory Services bought 1,275 DexCom shares in Q2 2026, an estimated $84.9K.
  • DexCom made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2581 holding.
  • Kestra Advisory Services first reported a position in DexCom in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's DexCom position peaked at $3.17M in Q4 2022.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.